UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
KB Financial Group
KB
$43.5B
| $593K | ﹤0.01% |
+21,300
| New | +$582K |
|
|
GLDD
2002
DELISTED
Great Lakes Dredge & Dock
GLDD
| $592K | ﹤0.01% |
63,920
+3,526
| +6% | +$30.8K |
|
2003
Argan
AGX
$8.37B
| $591K | ﹤0.01% |
12,477
-1,300
| -9% | -$49.7K |
|
2004
Veeco
VECO
$3.23B
| $591K | ﹤0.01% |
43,788
+1,503
| +4% | +$17.3K |
|
2005
Magnolia Oil & Gas
MGY
$5.94B
| $589K | ﹤0.01% |
97,129
-38,495
| -28% | -$210K |
|
2006
John B. Sanfilippo & Son
JBSS
$972M
| $587K | ﹤0.01% |
6,875
-2,092
| -23% | -$178K |
|
|
VCRA
2007
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $584K | ﹤0.01% |
27,564
+846
| +3% | +$16.6K |
|
2008
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| – | – |
0
| – | – |
|
2009
Crinetics Pharmaceuticals
CRNX
$8.92B
| $583K | ﹤0.01% |
+33,254
| New | +$567K |
|
2010
Tactile Systems Technology
TCMD
$665M
| $582K | ﹤0.01% |
14,056
+671
| +5% | +$31.4K |
|
|
GTHX
2011
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $579K | ﹤0.01% |
23,865
-187,248
| -89% | -$3.1M |
|
2012
Pennant Group
PNTG
$1.36B
| $579K | ﹤0.01% |
+25,609
| New | +$537K |
|
2013
G-III Apparel Group
GIII
$1.5B
| $577K | ﹤0.01% |
43,400
+4,513
| +12% | +$49.8K |
|
2014
Oxford Industries
OXM
$552M
| $576K | ﹤0.01% |
13,097
+7,359
| +128% | +$306K |
|
2015
Clearwater Paper
CLW
$376M
| $573K | ﹤0.01% |
15,871
+5,672
| +56% | +$158K |
|
2016
Cars.com
CARS
$660M
| $572K | ﹤0.01% |
99,304
+24,128
| +32% | +$133K |
|
2017
National Healthcare
NHC
$3.38B
| $572K | ﹤0.01% |
9,015
+1,337
| +17% | +$89.6K |
|
2018
First Financial Corp
THFF
$969M
| $571K | ﹤0.01% |
+15,494
| New | +$526K |
|
|
FOCS
2019
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $568K | ﹤0.01% |
17,200
+8,300
| +93% | +$208K |
|
|
KDMN
2020
DELISTED
Kadmon Holdings, Inc.
KDMN
| $568K | ﹤0.01% |
+110,890
| New | +$497K |
|
|
TVTY
2021
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $568K | ﹤0.01% |
50,108
-7,043
| -12% | -$64.3K |
|
|
EBSB
2022
DELISTED
Meridian Bancorp, Inc.
EBSB
| $564K | ﹤0.01% |
48,580
-5,596
| -10% | -$62.1K |
|
|
TGA
2023
DELISTED
Transglobe Energy Corp
TGA
| $563K | ﹤0.01% |
985,641
| – | – |
|
2024
MarineMax
HZO
$788M
| $561K | ﹤0.01% |
25,070
-11,367
| -31% | -$187K |
|
|
SHYF
2025
DELISTED
The Shyft Group
SHYF
| $561K | ﹤0.01% |
33,325
+10,705
| +47% | +$162K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.